Takahashi M, Iwatsuki N, Ono K, Tajima T, Akama M, Koga Y
Department of Anesthesiology, Tohoku University School of Medicine, Sendai, Japan.
Crit Care Med. 1992 Nov;20(11):1588-94. doi: 10.1097/00003246-199211000-00018.
Although hyperbaric oxygen therapy is clinically used for the treatment of several types of ischemic brain injury, few basic animal studies are available that provide a rationale for this therapy for complete global brain ischemia. Therefore, we investigated the effect of hyperbaric oxygen therapy on neurologic recovery after 15-min complete global cerebral ischemia in a canine model. Complete global ischemia was induced in 19 dogs by occlusion of the ascending aorta and the caval veins. Nine dogs were randomized to treatment with hyperbaric oxygenation (3 atmospheres absolute, 100% oxygen for 1 hr) at 3, 24, and 29 hrs after ischemia under spontaneous respiration, while the other ten dogs served as the control group without hyperbaric oxygen therapy (group C). Neurologic recovery was evaluated based on the electroencephalogram (EEG) activity score (1 = normal; 5 = isoelectric) and the neurologic recovery score (100 = normal; 0 = brain death) over a 14-day postischemic period.
The survival rates were 3/10 (30%) in the control group vs. 7/9 (78%) in the group treated with hyperbaric oxygen (p < .05). Over the 14-day postischemic period, the best (lowest) EEG scores of each dog were significantly (1.7 +/- 0.2 vs. 2.9 +/- 0.3; mean +/- SE, p < .01) lower in the hyperbaric oxygen-treated group. The best neurologic recovery scores of each dog were significantly (69 +/- 6 vs. 48 +/- 5; mean +/- SE, p < .05) higher in the treated animals. The number of dogs that recovered to a neurologic recovery score of > 65 (assessed as a slight disability) were 1/10 in the control group and 6/9 in the group treated with hyperbaric oxygen (p < .02).
Hyperbaric oxygen therapy performed in the early postischemic period accelerated neurologic recovery and improved the survival rate in dogs after 15-mins of complete global cerebral ischemia.
尽管高压氧疗法在临床上用于治疗多种类型的缺血性脑损伤,但很少有基础动物研究能为这种疗法用于完全性全脑缺血提供理论依据。因此,我们在犬模型中研究了高压氧疗法对15分钟完全性全脑缺血后神经功能恢复的影响。通过阻断升主动脉和腔静脉,在19只犬中诱导出完全性全脑缺血。9只犬在缺血后3、24和29小时,于自主呼吸状态下随机接受高压氧治疗(绝对压力3个大气压,100%氧气,持续1小时),另外10只犬作为未接受高压氧治疗的对照组(C组)。在缺血后14天内,根据脑电图(EEG)活动评分(1 = 正常;5 = 等电位)和神经功能恢复评分(100 = 正常;0 = 脑死亡)评估神经功能恢复情况。
对照组的存活率为3/10(30%),而高压氧治疗组为7/9(78%)(p < 0.05)。在缺血后14天内,高压氧治疗组每只犬的最佳(最低)EEG评分显著更低(1.7 ± 0.2对2.9 ± 0.3;平均值 ± 标准误,p < 0.01)。治疗动物每只犬的最佳神经功能恢复评分显著更高(69 ± 6对48 ± 5;平均值 ± 标准误,p < 0.05)。恢复到神经功能恢复评分> 65(评定为轻度残疾)的犬只数量,对照组为1/10,高压氧治疗组为6/9(p < 0.02)。
在缺血后早期进行的高压氧疗法可加速犬在15分钟完全性全脑缺血后的神经功能恢复并提高存活率。